Imported drugs for the treatment of gout, in the clinical mainly inhibit uric acid production of drugs such as febuxostat. In the clinical inhibition of uric acid production of drugs mainly choose febuxostat, is a new type of uric acid lowering drugs, can be used for mild to moderate renal insufficiency of patients, adverse reactions are mainly manifested as nausea, joint pain and liver function abnormalities. It is contraindicated in patients who are allergic to the drug, or who are being treated with azathioprine or mercaptopurine. Note that patients with severe renal failure should be used with caution, a liver function test should be performed before the first use of the drug, and liver and kidney function should be monitored during the use of the drug. Patients with gout are advised to consult the rheumatology and immunology departments of regular hospitals for treatment and follow the doctor’s instructions.